CASI Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: CASI Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: CASI Pharmaceuticals Inc
Rating: 1.43275
Author: Trendlyne DVM scores

about

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is us...

0.99 -0.01 (-1.00%)

67.96% Fall from 52W High

23,040

XNAS Volume

XNAS 22 Jan, 2026 4:00 PM (EST)

Not Eligible

Expensive Valuation

15.5 / 100

Technically Neutral

41.8 / 100

1Yr Price target upside is 304%

1 analysts

CASI Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

CASI Pharma Inc Live Stock Price Today, Share Analysis and Chart

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is us...

67.96% Fall from 52W High

SWOT Analysis

CASI Pharma Inc Live Price Chart